Indeed, in the hypoxic bone marrow (BM) microenvironment, HIF‐1α has been found to support the persistence of CML leukaemic stem cells (LSCs) in a BCR‐ABL kinase–independent manner.16 Here, HIF1A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.